RecruitingPhase 3NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
Clifton, NJ · Robbinsville, NJ · +45 more sites